November, 2024
November 2024
M T W T F S S
 123
45678910
11121314151617
18192021222324
252627282930  
Patrick Hwu: Moffitt Cancer Center has received Magnet designation
Jul 2, 2024, 13:46

Patrick Hwu: Moffitt Cancer Center has received Magnet designation

Patrick Hwu shared on LinkedIn:                     .

“On Monday, our nursing team received a call from the Chair of the Commission on Magnet, letting us know Moffitt Cancer Center has once again received Magnet designation! This marks the third time we have received the four-year designation from the American Nurses Credentialing Center.

Congratulations to Chief Nursing Officer Kelley Gonzalvo, Magnet Program Director Leslie Rogers, and the entire Moffitt team on this accomplishment! Magnet designation recognizes our excellence in nursing, culture, operations, and exceptional patient care. It reflects our nursing staff and the countless teams they partner with across disciplines.

In addition to being redesignated, we received exemplars – far exceeding the standard – in eight areas!”

Patrick Hwu: Moffitt Cancer Center has received Magnet designation

Source: Patrick Hwu/LinkedIn

Dr. Patrick Hwu, MD, currently serves as the President and CEO of Moffitt Cancer Center. With a focus on understanding the dynamics between tumors and the immune system, Dr. Hwu’s research has been pivotal in advancing gene-modified T cell therapy. He notably contributed seminal work on the development of the first chimeric antigen receptor aimed at combating cancer. His research portfolio extends to vaccines, adoptive T-cell therapies, and mechanisms of immune resistance.

Before joining, Dr. Hwu held numerous leadership roles at The University of Texas MD Anderson Cancer Center for over 17 years. Notably, he served as the inaugural Chairman of the Department of Melanoma Medical Oncology in 2003, as well as the Associate Director of the Center for Cancer Immunology Research. Additionally, he chaired the Department of Sarcoma Medical Oncology, demonstrating his commitment to advancing cancer treatment and research.